GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Debt-to-Equity

HLB Panagene Co (XKRX:046210) Debt-to-Equity : 0.36 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Debt-to-Equity?

HLB Panagene Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩23,406 Mil. HLB Panagene Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩3,974 Mil. HLB Panagene Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩76,043 Mil. HLB Panagene Co's debt to equity for the quarter that ended in Dec. 2024 was 0.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for HLB Panagene Co's Debt-to-Equity or its related term are showing as below:

XKRX:046210' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.18   Max: 1.71
Current: 0.36

During the past 13 years, the highest Debt-to-Equity Ratio of HLB Panagene Co was 1.71. The lowest was 0.00. And the median was 0.18.

XKRX:046210's Debt-to-Equity is ranked worse than
69.4% of 1013 companies
in the Biotechnology industry
Industry Median: 0.15 vs XKRX:046210: 0.36

HLB Panagene Co Debt-to-Equity Historical Data

The historical data trend for HLB Panagene Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co Debt-to-Equity Chart

HLB Panagene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.01 0.37 0.36

HLB Panagene Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.40 0.47 0.38 0.36

Competitive Comparison of HLB Panagene Co's Debt-to-Equity

For the Biotechnology subindustry, HLB Panagene Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's Debt-to-Equity falls into.



HLB Panagene Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

HLB Panagene Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

HLB Panagene Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Panagene Co  (XKRX:046210) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


HLB Panagene Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co Headlines

No Headlines